Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure.
10.3760/cma.j.cn501113-20220108-00008
- VernacularTitle:人工肝治疗肝衰竭模式选择及其疗效判断标准
- Author:
Li ZHOU
1
;
Yu CHEN
1
Author Information
1. Fourth Department of Liver Disease, Beijing You'an Hospital, Capital Medical University, Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
- Publication Type:Journal Article
- Keywords:
Artificial liver treatment;
Effect;
Hybrid mode;
Liver failure;
Therapy
- MeSH:
Hemodiafiltration;
Humans;
Judgment;
Liver Failure/therapy*;
Liver, Artificial;
Plasmapheresis
- From:
Chinese Journal of Hepatology
2022;30(2):127-130
- CountryChina
- Language:Chinese
-
Abstract:
Artificial liver is one of the effective methods to treat liver failure. Patients with liver failure are critically ill and have great individualized differences. Therefore, the specific program for the treatment of liver failure with artificial liver should be individualized. The commonly used non-biological artificial liver models include simple plasmapheresis, double filtration plasmapheresis, plasma filtration with dialysis, double plasma molecular adsorption system, molecular absorbent recirculating system, hemodiafiltration, continuous venovenous hemodiafiltration, hybrid, etc. The curative effect should be properly judged from patient's symptoms, laboratory test indicators, survival rate and other aspects after artificial liver therapy.
